Adherence to active surveillance monitoring among Medicare beneficiaries with prostate cancer
Authors:
- Jiaye ShenJSJiaye Shen
- Aaron J. KatzAKAaron J. Katz
- Yahui XieYXYahui Xie
- Ronald C. ChenRCRonald C. Chen
- Mutlay SayanMSMutlay Sayan
Open Access
- 2 November 2026
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerJAMA, 2024
- Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data BaseEuropean Urology, 2023
- Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate CancerNew England Journal of Medicine, 2023
- Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the USJAMA Network Open, 2023
- Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate CancerJournal of Urology, 2022
- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based ManagementJournal of Urology, 2022
- Receipt of Guideline-Recommended Surveillance in a Population-Based Cohort of Prostate Cancer Patients Undergoing Active SurveillanceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate CancerJournal of Urology, 2020
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerNew England Journal of Medicine, 2016
- Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in NoncompliersEuropean Urology, 2015